Veracyte Inc (VCYT)
20.35
+0.16
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
20.35
0.00 (0.00%)
After-Hours: 20:00
Veracyte Free Cash Flow: 34.26M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 34.26M |
| September 30, 2023 | 29.08M |
| June 30, 2023 | 23.02M |
| March 31, 2023 | 7.146M |
| December 31, 2022 | -1.014M |
| September 30, 2022 | -1.281M |
| June 30, 2022 | -9.798M |
| March 31, 2022 | -6.565M |
| December 31, 2021 | -37.00M |
| September 30, 2021 | -43.23M |
| June 30, 2021 | -38.91M |
| March 31, 2021 | -48.34M |
| December 31, 2020 | -12.55M |
| September 30, 2020 | -13.23M |
| June 30, 2020 | -16.14M |
| March 31, 2020 | -10.18M |
| December 31, 2019 | -5.988M |
| September 30, 2019 | -8.358M |
| June 30, 2019 | -9.012M |
| March 31, 2019 | -9.531M |
| December 31, 2018 | -15.40M |
| Date | Value |
|---|---|
| September 30, 2018 | -19.83M |
| June 30, 2018 | -23.22M |
| March 31, 2018 | -24.61M |
| December 31, 2017 | -25.67M |
| September 30, 2017 | -24.24M |
| June 30, 2017 | -26.02M |
| March 31, 2017 | -29.44M |
| December 31, 2016 | -32.19M |
| September 30, 2016 | -34.53M |
| June 30, 2016 | -31.84M |
| March 31, 2016 | -35.20M |
| December 31, 2015 | -33.13M |
| September 30, 2015 | -35.08M |
| June 30, 2015 | -37.27M |
| March 31, 2015 | -32.15M |
| December 31, 2014 | -29.66M |
| September 30, 2014 | -24.26M |
| June 30, 2014 | -22.50M |
| March 31, 2014 | -20.20M |
| December 31, 2013 | -20.49M |
Free Cash Flow Range, Past 5 Years
-48.34M
Minimum
Mar 2021
34.26M
Maximum
Dec 2023
-8.846M
Average
-9.012M
Median
Jun 2019
Free Cash Flow Benchmarks
| Fonar Corp | 12.18M |
| XWELL Inc | -18.45M |
| ProPhase Labs Inc | -14.50M |
| Applied DNA Sciences Inc | -7.592M |
| OncoCyte Corp | -23.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 15.55M |
| Cash from Investing (Quarterly) | -2.497M |
| Cash from Financing (Quarterly) | 0.645M |
| Free Cash Flow Per Share (Quarterly) | 0.1786 |
| Free Cash Flow to Equity (Quarterly) | 13.06M |
| Free Cash Flow to Firm (Quarterly) | 13.06M |
| Free Cash Flow Yield | 2.32% |